Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chronic Myeloid Leukaemia

Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse

Bone Marrow Transplantation volume 26, pages 1173–1177 (2000)Cite this article

Abstract

Autologous reconstitution is the recovery of autologous hematopoietic function after failure of an allogeneic graft to establish sustained hematopoiesis either with or without preceding donor engraftment. We reviewed 9 years experience of the University of Minnesota and identified 10 of 291 patients who underwent allogeneic BMT for Ph-positive CML and developed non-leukemic autologous reconstitution. All patients received the same preparative regimen with cyclophosphamide and total body irradiation. Eight patients had a 6/6-antigen matched donor. Eight patients received their graft from an unrelated donor. In five cases the graft was T cell-depleted. Non-malignant autologous reconstitution initially manifested as mixed chimerism in nine of 10 patients and lasted for a median of 11 (3–41) months. Eight patients have relapsed and four are still alive. The two relapse-free patients have died 24 and 48 months post transplant. Of the four surviving patients, two are in interferon-induced cytogenetic remission at 53+ and 101+ months of follow-up. Autologous non-leukemic reconstitution is uncommon, but appears to be a distinct clinical syndrome, perhaps occurring more frequently after unrelated donor BMT. Although usually followed by relapse, relapse-free survival may be prolonged. Bone Marrow Transplantation (2000) 26, 1173–1177.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Arthur CK, Apperley JF, Guo AP et al. Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase Blood 1988 71: 1179–1186

    CAS  PubMed  Google Scholar 

  2. Apperley JF, Jones L, Hale G et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse Bone Marrow Transplant 1986 1: 53–66

    CAS  PubMed  Google Scholar 

  3. Burnett AK, Hann IM, Robertson AG et al. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation Leukemia 1988 2: 300–303

    CAS  PubMed  Google Scholar 

  4. Bretagne S, Vidaud M, Kuentz M et al. Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms Blood 1987 70: 1692–1695

    CAS  PubMed  Google Scholar 

  5. Gardiner N, Lawler M, O'Riordan J et al. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia Bone Marrow Transplant 1997 20: 235–241

    Article  CAS  PubMed  Google Scholar 

  6. Roy DC, Tantravahi R, Murray C et al. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium Blood 1990 75: 296–304

    CAS  PubMed  Google Scholar 

  7. Fouillard L, Deconinck E, Tiberghien P et al. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation Bone Marrow Transplant 1998 21: 943–946

    Article  CAS  PubMed  Google Scholar 

  8. Kapoor N, Keever CA, Hsu SH et al. Prolonged remission of accelerated phase Philadelphia-chromosome negative chronic myeloid leukemia following autologous recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow transplantation Bone Marrow Transplant 1992 9: 143–145

    CAS  PubMed  Google Scholar 

  9. Okamoto T, Kanamaru A, Wada H et al. Hematopoietic recovery from host progenitors with normal karyotype devoid of Philadelphia chromosome in a patient with CML after allogeneic BMT Bone Marrow Transplant 1993 12: 89–92

    CAS  PubMed  Google Scholar 

  10. Serrano J, Roman J, Castillejo JA et al. Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML Bone Marrow Transplant 1998 22: 599–601

    Article  CAS  PubMed  Google Scholar 

  11. Sill H, Rule SA, Joske DJ et al. Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML Bone Marrow Transplant 1996 17: 453–455

    CAS  PubMed  Google Scholar 

  12. Wakui M, Okamoto S, Ishida A et al. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation Bone Marrow Transplant 1996 18: 801–804

    CAS  PubMed  Google Scholar 

  13. Blazar BR, Orr HT, Arthur DC et al. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation Blood 1985 66: 1436–1444

    CAS  PubMed  Google Scholar 

  14. Mitelman F . ISCN (1995): An International System for Human Cytogenetic Nomenclature Karger: Basel 1995

  15. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050

    CAS  PubMed  Google Scholar 

  16. Sehn LH, Alyea EP, Weller E et al. Comparative outcomes of T cell-depleted and non-T cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion J Clin Oncol 1999 17: 561–568

    Article  CAS  PubMed  Google Scholar 

  17. Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433–444

    Article  PubMed  Google Scholar 

  18. Drobyski WR, Hessner MJ, Klein JP et al. T cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation Blood 1999 94: 434–441

    CAS  PubMed  Google Scholar 

  19. Porter DL, Collins RH, Shiplberg O et al. Long-term follow-up of patients who achieved complete remission after donor lymphocyte infusion Biol Blood Marrow Transplant 1999 5: 253–261

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Blood and Bone Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA

    CG Brunstein, JS Miller, CM Verfaillie, PB McGlave & DJ Weisdorf

  2. Department of Laboratory Medicine and Pathology, Cytogenetics Laboratory, University of Minnesota, Minneapolis, MN, USA

    BA Hirsch

  3. Department of Laboratory Medicine and Pathology, Molecular Diagnostics Laboratory, University of Minnesota, Minneapolis, MN, USA

    RC McGlennen

Authors
  1. CG Brunstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. BA Hirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JS Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. RC McGlennen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. CM Verfaillie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. PB McGlave
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. DJ Weisdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brunstein, C., Hirsch, B., Miller, J. et al. Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse. Bone Marrow Transplant 26, 1173–1177 (2000). https://doi.org/10.1038/sj.bmt.1702696

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702696

Keywords

This article is cited by

Search

Advanced search

Quick links